tiprankstipranks
Advertisement
Advertisement

LUCD Stock Latest News

Lucid Diagnostics Shareholders Approve Stock Authorization Increase
Company AnnouncementsLucid Diagnostics Shareholders Approve Stock Authorization Increase
15d ago
8K
LUCD
Lucid Diagnostics price target lowered to $2 from $3 at Maxim
PremiumThe Fly
Lucid Diagnostics price target lowered to $2 from $3 at Maxim
2M ago
LUCD
Analyst Reiterates Buy on Lucid, Maintains $2.50 Price Target Ahead of Potential Medicare Catalyst
PremiumRatings
Analyst Reiterates Buy on Lucid, Maintains $2.50 Price Target Ahead of Potential Medicare Catalyst
2M ago
LUCD
Lucid Diagnostics Earnings Call Balances Progress, Pressure
PremiumCompany Announcements
Lucid Diagnostics Earnings Call Balances Progress, Pressure
2M ago
LUCD
Lucid Diagnostics reports Q1 adjusted EPS (7c), consensus (6c)
PremiumThe Fly
Lucid Diagnostics reports Q1 adjusted EPS (7c), consensus (6c)
2M ago
LUCD
Buy Rating Reaffirmed on Lucid Diagnostics as Medicare Coverage Prospects Support Unchanged $3 Price Target
PremiumRatingsBuy Rating Reaffirmed on Lucid Diagnostics as Medicare Coverage Prospects Support Unchanged $3 Price Target
2M ago
LUCD
Lucid Diagnostics Reports Q1 2026 Results and Outlook
Premium
Company Announcements
Lucid Diagnostics Reports Q1 2026 Results and Outlook
2M ago
8K
LUCD
LUCD Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
LUCD Earnings this Week: How Will it Perform?
2M ago
LUCD
Lucid Diagnostics Raises Capital Through Direct Share Offering
PremiumCompany Announcements
Lucid Diagnostics Raises Capital Through Direct Share Offering
3M ago
8K
LUCD
Lucid Diagnostics Prices $18 Million Public Equity Offering
PremiumCompany Announcements
Lucid Diagnostics Prices $18 Million Public Equity Offering
3M ago
8K
LUCD
Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering
PremiumThe Fly
Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering
3M ago
LUCD
Lucid Diagnostics: Advancing EsoGuard Volume Growth and Reimbursement Visibility Supports Buy Rating
PremiumRatings
Lucid Diagnostics: Advancing EsoGuard Volume Growth and Reimbursement Visibility Supports Buy Rating
3M ago
LUCD
Lucid Diagnostics price target raised to $9 from $8.25 at Ascendiant
PremiumThe FlyLucid Diagnostics price target raised to $9 from $8.25 at Ascendiant
3M ago
LUCD
Lucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain
Premium
Company Announcements
Lucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain
3M ago
LUCD
Is LUCD a Buy, Before Earnings?
Premium
Pre-Earnings
Is LUCD a Buy, Before Earnings?
3M ago
LUCD
Lucid Diagnostics Reports Q4 2025 Results, Highlights VA Contract
PremiumCompany Announcements
Lucid Diagnostics Reports Q4 2025 Results, Highlights VA Contract
4M ago
8K
LUCD
Lucid Diagnostics reports Q4 adjusted EPS (10c) vs. (19c) last year
PremiumThe Fly
Lucid Diagnostics reports Q4 adjusted EPS (10c) vs. (19c) last year
4M ago
LUCD
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
6M ago
AMD
DIA
Why Are PAVmed (PAVM) & Lucid Diagnostics (LUCD) Stocks Up Today?
PremiumMarket News
Why Are PAVmed (PAVM) & Lucid Diagnostics (LUCD) Stocks Up Today?
6M ago
LUCD
PAVM
Lucid Diagnostics awarded U.S. Dept of Veterans Affairs contract for EsoGuard
PremiumThe FlyLucid Diagnostics awarded U.S. Dept of Veterans Affairs contract for EsoGuard
6M ago
LUCD
PAVM
Lucid Diagnostics price target raised to $8.25 from $8 at Ascendiant
Premium
The Fly
Lucid Diagnostics price target raised to $8.25 from $8 at Ascendiant
7M ago
LUCD
Lucid Diagnostics’ esophageal precancer detection tools show efficacy in study
Premium
The Fly
Lucid Diagnostics’ esophageal precancer detection tools show efficacy in study
7M ago
LUCD
PAVM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >